Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do we need a better test? Can thrombin generation be useful?

Louis M Aledort1

  • 1Clinical Research in Hemophilia, Mount Sinai School of Medicine, New York, NY 10029, USA. louis.aledort@msnyuhealth.org

Current Hematology Reports
|February 18, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emicizumab in Hemophilia A. Reply.

The New England journal of medicine·2020
Same author

Deaths Associated with Emicizumab in Patients with Hemophilia A.

The New England journal of medicine·2019
Same author

The ongoing imperative for immune tolerance induction in inhibitor management.

Haemophilia : the official journal of the World Federation of Hemophilia·2019
Same author

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

The New England journal of medicine·2017
Same author

Treatment of Congenital Thrombotic Thrombocytopenia Purpura: A New Paradigm.

Journal of pediatric hematology/oncology·2017
Same author

A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia.

Blood·2014